Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Volume 1863, Issue 7, Part B, July 2016, Pages 1799-1805
ReviewThe role of mutations in the SCN5A gene in cardiomyopathies☆
Under an Elsevier user license
open archive
Abbreviations
AF
atrial fibrillation
AHA
American Heart Association
AP
action potential
ARVC
arrhythmogenic right ventricular cardiomyopathy
AtSt
Atrial standstill
AV
atrio-ventricular
AVB
artio-venrticular block
CMP
cardiomyopathy
CP
cytoplasmic
CRT
cardiac resynchronization therapy
CRT-D
cardiac resynchronization therapy with defibrillator function
CRT-P
cardiac resynchronization therapy with pacemaker function
DCM
dilated cardiomyopathy
EC
extracellular
ECG
electrocardiogram
ESC
European Society of Cardiology
EHRA
European Heart Rhythm Association
ICD
implantable cardioverter defibrillator
ISFC
International Society and Federation of Cardiology
LQT3
Long QT syndrome, type 3
LQTS
Long QT syndrome
HCM
hypertrophic cardiomyopathy
HRS
Heart Rhythm Society
LVNC
left ventricular non-compaction
NGS
new generation sequencing
PVC
premature ventricular contractions
RVOT
right ventricular outflow tract
SCD
sudden cardiac death
SIDS
sudden infant death syndrome
SSS
sick sinus syndrome
TM
transmembrane
VT
ventricular tachycardia
WHF
World Heart Federation
WHO
World Health Organization
Keywords
SCN5A
Nav1.5
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy
Cardiac remodeling
Cited by (0)
- ☆
This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
© 2016 Elsevier B.V.